Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial
- PMID: 22974139
- PMCID: PMC3525782
- DOI: 10.1111/j.1747-4949.2012.00894.x
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial
Abstract
Rationale: Multimodal imaging has the potential to identify acute ischaemic stroke patients most likely to benefit from late recanalization therapies.
Aims: The general aim of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy Trial is to investigate whether multimodal imaging can identify patients who will benefit substantially from mechanical embolectomy for the treatment of acute ischaemic stroke up to eight-hours from symptom onset.
Design: Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy is a randomized, controlled, blinded-outcome clinical trial.
Population studied: Acute ischaemic stroke patients with large vessel intracranial internal carotid artery or middle cerebral artery M1 or M2 occlusion enrolled within eight-hours of symptom onset are eligible. The study sample size is 120 patients.
Study intervention: Patients are randomized to endovascular embolectomy employing the Merci Retriever (Concentric Medical, Mountain View, CA) or the Penumbra System (Penumbra, Alameda, CA) vs. standard medical care, with randomization stratified by penumbral pattern.
Outcomes: The primary aim of the trial is to test the hypothesis that the presence of substantial ischaemic penumbral tissue visualized on multimodal imaging (magnetic resonance imaging or computed tomography) predicts patients most likely to respond to mechanical embolectomy for treatment of acute ischaemic stroke due to a large vessel, intracranial occlusion up to eight-hours from symptom onset. This hypothesis will be tested by analysing whether pretreatment imaging pattern has a significant interaction with treatment as a determinant of functional outcome based on the distribution of scores on the modified Rankin Scale measure of global disability assessed 90 days post-stroke. Nested hypotheses test for (1) treatment efficacy in patients with a penumbral pattern pretreatment, and (2) absence of treatment benefit (equivalency) in patients without a penumbral pattern pretreatment. An additional aim will only be tested if the primary hypothesis of an interaction is negative: that patients treated with mechanical embolectomy have improved functional outcome vs. standard medical management.
Keywords: MRI; clinical trial; embolectomy; ischaemic stroke; neuroimaging; penumbra.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.
Conflict of interest statement
Conflicts of Interest and Disclosures:
Dr. Jahan has served on the speakers’ bureau for Concentric Medical, Inc. and serves as a consultant for ev3, Inc. The University of California, Regents receive funding for Dr. Saver’s services as a scientific consultant regarding trial design and conduct to ev3 and Grifols. Drs. Jahan, Alger, Starkman, Elashoff, Gornbein, Nenov, and Saver, and Ms. Guzy are employees of the University of California, which holds a patent on Merci Retriever devices for stroke.
Similar articles
-
A trial of imaging selection and endovascular treatment for ischemic stroke.N Engl J Med. 2013 Mar 7;368(10):914-23. doi: 10.1056/NEJMoa1212793. Epub 2013 Feb 8. N Engl J Med. 2013. PMID: 23394476 Free PMC article. Clinical Trial.
-
Surgical embolectomy for large vessel occlusion of anterior circulation.Br J Neurosurg. 2013 Dec;27(6):783-90. doi: 10.3109/02688697.2013.793286. Epub 2013 May 9. Br J Neurosurg. 2013. PMID: 23659199
-
REVASCAT: a randomized trial of revascularization with SOLITAIRE FR device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset.Int J Stroke. 2015 Jun;10(4):619-26. doi: 10.1111/ijs.12157. Epub 2013 Nov 10. Int J Stroke. 2015. PMID: 24206399 Clinical Trial.
-
Advances in endovascular treatment of acute ischaemic stroke.Intern Med J. 2015 Aug;45(8):798-805. doi: 10.1111/imj.12652. Intern Med J. 2015. PMID: 25443686 Review.
-
Direct Microsurgical Embolectomy for Acute Occlusion of the Internal Carotid Artery and Middle Cerebral Artery.World Neurosurg. 2016 Apr;88:243-251. doi: 10.1016/j.wneu.2015.12.069. Epub 2015 Dec 31. World Neurosurg. 2016. PMID: 26748169 Review.
Cited by
-
Endovascular therapy for ischemic stroke.J Clin Neurol. 2015 Jan;11(1):1-8. doi: 10.3988/jcn.2015.11.1.1. Epub 2015 Jan 2. J Clin Neurol. 2015. PMID: 25628731 Free PMC article. Review.
-
Stent retrievers in acute ischemic stroke: complications and failures during the perioperative period.AJNR Am J Neuroradiol. 2014 Apr;35(4):734-40. doi: 10.3174/ajnr.A3746. Epub 2013 Oct 24. AJNR Am J Neuroradiol. 2014. PMID: 24157734 Free PMC article. Clinical Trial.
-
Neuroimaging of cerebral ischemia and infarction.Neurotherapeutics. 2011 Jan;8(1):19-27. doi: 10.1007/s13311-010-0004-2. Neurotherapeutics. 2011. PMID: 21274682 Free PMC article. Review.
-
Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.BMJ. 2016 Apr 18;353:i1754. doi: 10.1136/bmj.i1754. BMJ. 2016. PMID: 27091337 Free PMC article.
-
A trial of imaging selection and endovascular treatment for ischemic stroke.N Engl J Med. 2013 Mar 7;368(10):914-23. doi: 10.1056/NEJMoa1212793. Epub 2013 Feb 8. N Engl J Med. 2013. PMID: 23394476 Free PMC article. Clinical Trial.
References
-
- Fisher M. Characterizing the target of acute stroke therapy. Stroke. 1997;28(4):866–72. - PubMed
-
- NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine. 1995;333:1581–7. - PubMed
-
- Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 6;363(9411):768–74. - PubMed
-
- Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010 May 15;375(9727):1695–703. - PubMed
-
- Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317–29. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical